# China National Registry of Neuro-Inflammatory Diseases

> **NCT05154370** · — · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 10000 (estimated)

## Conditions studied

- Multiple Sclerosis
- NMO Spectrum Disorder
- Clinically Isolated Syndrome
- CNS Demyelinating Autoimmune Diseases
- Acute Disseminated Encephalomyelitis
- Primay Angiitis of the Central Nervous System
- Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy

## Interventions

- **DRUG:** Intravenous steroid

## Key facts

- **NCT ID:** NCT05154370
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-15
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2023-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05154370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05154370, "China National Registry of Neuro-Inflammatory Diseases". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05154370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*